GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms?
作者信息
Ong John, Dan Yock Young
机构信息
Department of Medicine, National University of Singapore, Singapore, Singapore.
Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, CB2 1PZ, UK.
出版信息
Dig Dis Sci. 2021 Oct;66(10):3228-3230. doi: 10.1007/s10620-020-06767-5. Epub 2021 Jan 11.
Abstract
摘要
相似文献
1
GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms?
Dig Dis Sci. 2021 Oct;66(10):3228-3230. doi: 10.1007/s10620-020-06767-5. Epub 2021 Jan 11.
2
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.
Gastroenterology. 2021 Jun;160(7):2435-2450.e34. doi: 10.1053/j.gastro.2021.02.056. Epub 2021 Mar 4.
3
Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings.
World J Gastroenterol. 2021 Feb 14;27(6):449-469. doi: 10.3748/wjg.v27.i6.449.
4
Editorial: Proteins of SARS CoV-2, the Cause of COVID-19, and the Proteins that Interact with Them.
Protein J. 2020 Dec;39(6):599. doi: 10.1007/s10930-020-09947-4. Epub 2020 Dec 5.
5
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.
6
Gastrointestinal Symptoms Onset in COVID-19 Patients in Wuhan, China.
Dig Dis Sci. 2021 Oct;66(10):3578-3587. doi: 10.1007/s10620-020-06693-6. Epub 2020 Nov 12.
7
Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms.
Gut. 2021 Feb;70(2):436-438. doi: 10.1136/gutjnl-2020-321486. Epub 2020 May 19.
8
COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
World J Gastroenterol. 2021 Apr 14;27(14):1406-1418. doi: 10.3748/wjg.v27.i14.1406.
9
Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2.
J Zhejiang Univ Sci B. 2020;21(9):749-751. doi: 10.1631/jzus.B2000253.
10
Chronobiology in response to COVID-19.
J Biol Rhythms. 2021 Feb;36(1):3. doi: 10.1177/0748730421993352. Epub 2021 Feb 5.
引用本文的文献
1
The relationship between the serotonergic system and COVID-19 disease: A review.
Heliyon. 2022 May;8(5):e09544. doi: 10.1016/j.heliyon.2022.e09544. Epub 2022 May 26.
2
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line.
Phytother Res. 2021 Dec;35(12):6893-6903. doi: 10.1002/ptr.7302. Epub 2021 Oct 12.
3
Jaundice in patients with COVID-19.
JGH Open. 2021 Aug 24;5(10):1166-1171. doi: 10.1002/jgh3.12645. eCollection 2021 Oct.
本文引用的文献
1
Gastrointestinal Symptoms Onset in COVID-19 Patients in Wuhan, China.
Dig Dis Sci. 2021 Oct;66(10):3578-3587. doi: 10.1007/s10620-020-06693-6. Epub 2020 Nov 12.
2
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
Nat Struct Mol Biol. 2020 Dec;27(12):1202-1208. doi: 10.1038/s41594-020-00536-8. Epub 2020 Nov 11.
3
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission.
Aliment Pharmacol Ther. 2020 Oct;52(8):1276-1288. doi: 10.1111/apt.16036. Epub 2020 Aug 27.
4
Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study.
Am J Gastroenterol. 2020 Oct;115(10):1609-1616. doi: 10.14309/ajg.0000000000000805.
5
AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.
Gastroenterology. 2020 Jul;159(1):320-334.e27. doi: 10.1053/j.gastro.2020.05.001. Epub 2020 May 11.
Zotero 插件